Neural and Nonneural Contributions to Wrist Rigidity in Parkinson's Disease: An Explorative Study Using the NeuroFlexor

di Zetterberg, H., Frykberg, G. E., Gäverth, J., Lindberg, P. G.
Pubblicato in Biomed Res Int (2015)

Cerebrospinal fluid GAP-43 in early multiple sclerosis

di Rot, U, Sandelius, Å, Emeršič, A, Zetterberg, H, Blennow, K
Pubblicato in Mult Scler J Exp Transl Clin (2018)

CSF evidence of pericyte damage in Alzheimer’s disease is associated with markers of blood-brain barrier dysfunction and disease pathology

di Miners, J. S., Kehoe, P. G., Love, S., Zetterberg, H., Blennow, K.
Pubblicato in Alzheimers Res Ther (2019)

A STUDY ON THE RELATION BETWEEN SLEEP AND BETA-AMYLOID-42 IN CEREBROSPINAL FLUID IN 70-YEAR-OLDS

di Skoog, J., Kern, S., Zetterberg, H., Blennow, K., Johansson, B., Skoog, I.
Pubblicato in Innov Aging (2017)

Amyloid precursor like protein 1 in Idiopathic Normal Pressure hydrocephalus; expanding the knowledge of an altered amyloid metabolism

di Jeppsson, A, Höltta, M, Zetterberg, H, Blennow, K, Wikkelsø, C, Tullberg, M
Pubblicato in Fluids Barriers CNS (2015)

Amyloid mis-metabolism in idiopathic normal pressure hydrocephalus

di Jeppsson, A., Höltta, Mikko, Zetterberg, H., Blennow, K., Wikkelsø, C., Tullberg, Mats
Pubblicato in Fluids Barriers CNS (2016)

Preclinical amyloid pathology biomarker positivity: effects on tau pathology and neurodegeneration

di Höglund, K, Kern, S, Zettergren, A, Börjesson-Hansson, A, Zetterberg, H, Skoog, I, Blennow, K
Pubblicato in Transl Psychiatry (2017)

Correction: Preclinical amyloid pathology biomarker positivity: effects on tau pathology and neurodegeneration

di Höglund, K., Kern, S., Zettergren, A., Börjesson-Hansson, A., Zetterberg, H., Skoog, I., Blennow, K.
Pubblicato in Transl Psychiatry (2018)

Abnormality in glutamine–glutamate cycle in the cerebrospinal fluid of cognitively intact elderly individuals with major depressive disorder: a 3-year follow-up study

di Hashimoto, K, Bruno, D, Nierenberg, J, Marmar, C R, Zetterberg, H, Blennow, K, Pomara, N
Pubblicato in Transl Psychiatry (2016)

γ-Secretase-dependent amyloid-β is increased in Niemann-Pick type C: A cross-sectional study

di Mattsson, N., Zetterberg, H., Bianconi, S., Yanjanin, N.M., Fu, R., Månsson, J.-E., Porter, F.D., Blennow, K.
Pubblicazione 2011

CSF protein biomarkers predicting longitudinal reduction of CSF β-amyloid42 in cognitively healthy elders

di Mattsson, N, Insel, P, Nosheny, R, Zetterberg, H, Trojanowski, J Q, Shaw, L M, Tosun, D, Weiner, M
Pubblicazione 2013

Polymorphisms in dopamine‐associated genes and cognitive decline in Parkinson's disease

di Bäckström, D., Eriksson Domellöf, M., Granåsen, G., Linder, J., Mayans, S., Elgh, E., Zetterberg, H., Blennow, K., Forsgren, L.
Pubblicato in Acta Neurol Scand (2017)

Quantification of total apolipoprotein E and its isoforms in cerebrospinal fluid from patients with neurodegenerative diseases

di Minta, K., Brinkmalm, G., Janelidze, S., Sjödin, S., Portelius, E., Stomrud, E., Zetterberg, H., Blennow, K., Hansson, O., Andreasson, U.
Pubblicato in Alzheimers Res Ther (2020)

Cognitive function in very old men does not correlate to biomarkers of Alzheimer’s disease

di Velickaite, V., Giedraitis, V., Ström, K., Alafuzoff, I., Zetterberg, H., Lannfelt, L., Kilander, L., Larsson, E-M., Ingelsson, M.
Pubblicato in BMC Geriatr (2017)

Cerebrospinal fluid-induced retardation of amyloid β aggregation correlates with Alzheimer's disease and the APOE ε4 allele

di Padayachee, E.R., Zetterberg, H., Portelius, E., Borén, J., Molinuevo, J.L., Andreasen, N., Cukalevski, R., Linse, S., Blennow, K., Andreasson, U.
Pubblicato in Brain Res (2016)

Apolipoprotein E polymorphism in patients with cataract

di Zetterberg, M, Zetterberg, H, Palmér, M, Rymo, L, Blennow, K, Tasa, G, Juronen, E, Veromann, S, Teesalu, P, Karlsson, J-O, Höglund, K
Pubblicazione 2004

Cerebrospinal fluid markers including trefoil factor 3 are associated with neurodegeneration in amyloid-positive individuals

di Paterson, R W, Bartlett, J W, Blennow, K, Fox, N C, Shaw, L M, Trojanowski, J Q, Zetterberg, H, Schott, J M
Pubblicazione 2014

Biomarkers in dementia: clinical utility and new directions

di Ahmed, R M, Paterson, R W, Warren, J D, Zetterberg, H, O'Brien, J T, Fox, N C, Halliday, G M, Schott, J M
Pubblicato in J Neurol Neurosurg Psychiatry (2014)

CSF biomarkers for Alzheimer's pathology and the effect size of APOE ɛ4

di Andreasson, U, Lautner, R, Schott, J M, Mattsson, N, Hansson, O, Herukka, S-K, Helisalmi, S, Ewers, M, Hampel, H, Wallin, A, Minthon, L, Hardy, J, Blennow, K, Zetterberg, H
Pubblicazione 2014

A Comparison of Biofluid Cytokine Markers across Platform Technologies: Correspondence or Divergence?

di Casaletto, K.B., Elahi, F.E., Fitch, R., Walters, S., Fox, E., Staffaroni, A.M., Bettcher, B., Zetterberg, H., Karydas, A., Rojas, J.C., Boxer, A.L., Kramer, J.H.
Pubblicato in Cytokine (2018)